Globalepolicy.org is a free to access global medical news service for the consumer, professional and researcher.
Our adviser: Drugs Infromation online
Background: A treatment algorithm and screening examination have been developed to guide patient management and prospectively determine potential for highly active individuals to succeed with nonoperative care after anterior cruciate ligament rupture.
Objective: To prospectively characterize and classify the entire population of highly active individuals over a 10-year period and provide final outcomes for individuals who elected nonoperative care.
Methods: Inclusion criteria included presentation within 7 months of the index injury and an International Knee Documentation Committee level I or II activity level before injury. Concomitant injury, unresolved impairments, and a screening examination were used as criteria to guide management and classify individuals as noncopers (poor potential) or potential copers (good potential) for nonoperative care.
Results: A total of 832 highly active patients with subacute anterior cruciate ligament tears were seen over the 10-year period; 315 had concomitant injuries, 87 had unresolved impairments, and 85 did not participate in the classification algorithm. The remaining 345 patients (216 men, 129 women) participated in the screening examination a mean of 6 weeks after the index injury. There were 199 subjects classified as noncopers and 146 as potential copers. Sixty-three of 88 potential copers successfully returned to preinjury activities without surgery, with 25 of these patients not undergoing anterior cruciate ligament reconstruction at the time of follow-up.
Conclusion: The classification algorithm is an effective tool for prospectively identifying individuals early after anterior cruciate ligament injury who want to pursue nonoperative care or must delay surgical intervention and have good potential to do so.
NAVIGATION
|
31
May |
NICE Draft Guidance On X-ray Imaging System Published For ConsultationCategory: Radiology / Nuclear Medicine | Leave a Comment |
Draft guidance from the new NICE Diagnostics Assessment Programme on a 2D/3D x-ray imaging system is issued today for consultation. The provisional recommendations, the first to be published under the new programme, do not support the routine use of the EOS 2D/3D X-ray imaging system in the NHS…
|
31
May |
Reliable Diagnosis Of Bladder Dysfunction Using Non-Invasive Wireless Near-Infrared DeviceCategory: Urology / Nephrology | Leave a Comment |
A cell phone-sized, wireless near-infrared device is as reliable as the current “gold standard” invasive tests in determining bladder disease, according to a study by researchers at the University of British Columbia, Vancouver Coastal Health and the Child & Family Research Institute (CFRI)…
|
31
May |
Radiometer’s AQT90 FLEX Helps Rule Out VTECategory: Medical Devices / Diagnostics | Leave a Comment |
Radiometer’s AQT90 FLEX is a compact and cost-effective point of care immunoassay analyser offering rapid turnaround times for determination of critical biomarkers, such as D-dimer, and provides a valuable diagnostic tool for ruling out venous thromboembolism (VTE)…
|
31
May |
MEDMIX Systems AG Announces Bone Graft Delivery SystemCategory: Bones / Orthopedics | Leave a Comment |
MEDMIX Systems AG has developed a range of syringes for the preparation of bone graft, autograft, allograft or synthetic variants thereof. The new product line will be featured at 12th EFORT Congress, Copenhagen, Denmark, organized by the European Federation of National Associations of Orthopeaedics and Traumatology. Visit MEDMIX at booth #C3/067 from June 1 - 3, 2011…
This Memorial Day weekend at the 2011 Annual ACA Meeting, Bruker will launch a new series of high-performance X-ray crystallography systems, including the D8 QUEST™ and the D8 VENTURE™. Both systems incorporate next-generation X-ray source and novel detector technology to deliver unrivalled performance, ease of use, reliability and value…
|
31
May |
Augurex Reports Positive Data For RA Blood Test And Drug Target At The Annual European Congress Of Rheumatology (EULAR)Category: Arthritis / Rheumatology | Leave a Comment |
Augurex Life Sciences Corp. reported that in London at the European League Against Rheumatism (EULAR) Conference, leading arthritis researchers presented important data on Augurex’s rheumatoid arthritis (RA) biomarker blood test and novel drug target…
|
30
May |
Clinical Trial Of Mobile Health Monitoring Solution Starts In SingaporeCategory: Clinical Trials / Drug Trials | Leave a Comment |
HP, SingTel, HealthSTATS and Frontier Healthcare Group today announced an 8-week clinical trial of a mobile health monitoring solution. The solution enables near real time information sharing to help healthcare professionals in the early detection, treatment and prevention of cardiovascular conditions. Cardiovascular diseases accounted for more than 31 percent of all deaths in Singapore in 20091…
|
30
May |
Making Brain Surgery SaferCategory: Neurology / Neuroscience | Leave a Comment |
Brain interventions must be planned so that the neurosurgeon can access and remove the tumor without causing unnecessary damage. Before the brain tumor can be removed, crucial questions must be answered…
|
30
May |
Fluorescent Nanotubes Enable Clearer Imaging Of Internal Organs Of A MouseCategory: Medical Devices / Diagnostics | Leave a Comment |
Developing drugs to combat or cure human disease often involves a phase of testing with mice, so being able to peer clearly into a living mouse’s innards has real value…
|
30
May |
$4.7-Million Study On Early-Stage Oral CancerCategory: Cancer / Oncology | Leave a Comment |
Researchers from UBC’s Faculties of Medicine, Science and Dentistry are leading a $4.7 million pan-Canadian clinical trial aimed at improving outcomes for patients undergoing surgery for oral squamous cell cancers…